← Evidence map

ArticleEBioMedicine2019

MYC status as a determinant of synergistic response to Olaparib and Palbociclib in ovarian cancer.

Jingyan Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

59 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 30898650